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Summary The sites of tumour development for 6 rat tumours injected into syngeneic rats via different
vascular routes was determined. Xenografts of human tumours were also injected intra-arterially (i.a.) into
immunosuppressed rats.
Following intravenous (i.v.) and intraportal (i.ptl.) injection of cells tumour colonies localised in lung and
liver respectively due to tumour cell arrest. Arterially injected radiolabelled cells disseminated and arrested in
a similar distribution to cardiac output and did not 'home' to any organs. Following arterial injection of
unlabelled tumour cells colonies grew in many organs. While the pattern of growth for a particular tumour
varied with the cell dose, the 'arterial patterns' for all of the tumours studied followed a similar pattern. Some
organs (eg adrenals, ovaries and periodontal ligament) were consistently preferred, others (eg skin and skeletal
muscle) only supported tumour growth following the delivery of large numbers of cells, while in some tissues
(eg spleen and intestines) tumour never grew.
Viable tumour cells could be demonstrated by bioassay in many organs for up to 24h after i.a. injection.
However tumour growth only occurred in certain organs and the pattern of this growth was not related to the
number of tumour cells arrested or their rate of autolysis. This site preference could be expressed
quantitatively as the probability of an arrested cell developing into a tumour and was considered a 'soil
effect'. Site preference was not directly related to organ vascularity. Organ colonisation was promoted by
steroid treatment but the mechanism was unclear and was not secondary to T-cell immunosuppression or
prostaglandin synthesis suppression. The adrenal glands were preferred sites of tumour growth but
pharmacological manipulation of adrenal function did not alter tumour growth to this organ. Sites of injury
and healing were preferred sites of tumour colonisation and this could not be accounted for by increased
delivery of tumour cells to these regions. The possibility that the macrophage component of the inflammatory
response promoted tumour growth was suggested from studies in which the interval between trauma and
inoculation of tumour cells was varied as well as by promotion of intraperitoneal (i.p.) tumour growth by a
macrophage infiltrate.
In explaining the mechanism of site selectivity by bloodborne
metastasis the haemodynamic theory of Ewing (1928)
stressed the importance of the mechanics of the circulation
whereas the Soil/Seed hypothesis of Paget (1889) emphasized
the importance of the environment in which the trapped
emboli found themselves. The eventual sites of metastasis
are, however, determined by both haemodynamic and
soil/seed factors. Haemodynamic factors are important
following the venous discharge of tumour cells since the
'organs of first encounter' are the commonest site for
bloodborne metastasis - the lung after systemic venous
discharge of tumour cells and the liver after portal venous
discharge (Viadana et al., 1978). The present study
emphasizes that the 'soil' becomes important when tumour
cells have entered the systemic arterial circulation and are
thereby delivered to all organs. Clinically this situation can
occur when cells are released from primary or secondary
lung tumours or possibly when cells released into the venous
circulation manage to traverse the lung capillaries.
In this paper we extend earlier data (Murphy et al., 1986)
on the pattern of spread of rat syngeneic non-lymphoid and
non-haemopoietic tumours following intravenous (i.v.),
intraportal (i.ptl.) and intra-arterial (i.a.) injection. In our i.v.
and i.ptl. studies as well as previously reported studies
tumour growth is essentially limited to the 'organs of first
encounter' and the study of mechanisms of site selectivity is
therefore limited. In order to deliver tumour cells to all
organs we have injected them intra-arterially via the
intracardiac (i.c.) route. Labelled cell distribution after i.c.
injection has been compared with the distribution of cardiac
output (measured using the microsphere technique) in order
to establish whether cells disseminate and arrest passively or
whether they recirculate and localise in certain organs. The
'arterial pattern' of tumour growth after unlabelled cell
injection has then been compared with the arterial
distribution of labelled tumour cells to establish and
quantitate the 'soil effect'.
Having established a 'soil effect' after arterial injection of
tumour cells we have attempted to determine the
mechanisms using several approaches. Firstly a correlation
of site selectivity with organ vascularity (using data obtained
from the microsphere studies) was sought since there have
been reports that more vascular organs might be more
susceptible to metastasis (Weiss et al., 1981). Secondly the
rate of autolysis of trapped labelled cells in different organs
has been compared with the organs susceptibility to tumour
growth. Thirdly we have intervened pharmacologically to see
if site preference can be altered and finally we have rendered
refractory organs susceptible to tumour growth by trauma.
The pharmacological studies took two directions. Because
steroids promoted sarcoma and hepatoma tumour growth in
liver and kidney possible steroid dependence of the sarcoma
was looked for by testing if adrenalectomy inhibited tumour
growth. To establish if the steroid potentiating effect was
related to T-cell immunosuppression or inhibition of prosta-
glandin synthesis the animals were treated with cyclosporin
A or a non-steroidal anti-inflammatory agent flurbiprofen.
As the adrenal gland in our studies was found to be a
universally preferred site of tumour colonisation the
possibility that locally high steroid concentrations in the
adrenal provided an environment conducive to tumour
growth as examined by testing if the steroid inhibitors
metyrapone and aminoglutethimide inhibited tumour growth
in the adrenal. We did not test the role of catecholamines in
adrenal preference by interfering with it's tissue levels but
instead studied the effect of blocking the beta action of
catecholamines with propranolol.
We found that sites of trauma or healing were especially
susceptible to tumour growth. The possibility that this was
related to increased bloodflow and hence increased delivery
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of tumour cells was eliminated using the microsphere
method. The possibility that it was related to the
macrophage response of the inflammatory process was then
studied in an intraperitoneal (i.p.) system. The omentum was
found to be very susceptible to tumour growth after i.p.
injection of tumour cells. This organ is very rich in
monocytes and macrophages (Liebermann-Meffert & White,
1983) and following local administration of the branched
chain hydrocarbon pristane there is a dramatic enlargement
of the omentum (Leak et al., 1985) and production of a
exudate rich in macrophages which, however, are not
cytocidal (Alexander, 1976). If macrophages were responsible
for promoting the growth of cancer cells at sites of
inflammation or injury then pretreatment with pristane
should facilitate the growth of i.p. tumour cells.
Materials and methods
Animals
The studies employed syngeneic hooded Lister rats which
were initially obtained from the Institute of Cancer Research
at Sutton. Males weighed 200-330g and females 150-250g.
Anaesthesia
The animals were anaesthetised using open ether.
Injections
I.v. injections were made through cannulae placed in the
right jugular vein. I.ptl. vein injections were made directly
into the portal vein or alternatively into one of the
mesenteric ileal tributaries of the portal vein.
I.a. injections were made through cannulae (Portex
800/100/100) inserted retrogradely via the right carotid artery
into the left ventricle of the ether anaesthetized rat. In early
studies the animals were allowed to wake and were then
injected. In later studies, when cannulation was performed
more rapidly, tumour cells were injected into anaesthetised
rats at the time of cannulation and this became the preferred
method of injection.
Tumours
Six chemically induced syngeneic to the hooded Lister rat
were used in the intravascular experiments (Table I). A
seventh tumour, the methylcholanthrene induced sarcoma
MC26, was only used in the intraperitoneal experiments. Six
tumours had been induced at the Chester Beatty Institute of
Cancer Research and one in Southampton (the breast
carcinoma- Senior et al., 1985). They were passaged s.c. and
the passage number was not observed to affect the growth
pattern of the tumours after i.v. injection.
Human tumours were also injected i.a. into immuno-
suppressed rats. These tumours had all previously been
passaged in athymic nude mice. Melanoma HX34 and
carcinoma HX70 was passaged in cyclosporin A treated rats
(given s.c. at a dose of 25 mgkg 1 four times per week) prior
to i.c. injection into further cyclosporin A treated rats.
Melanoma HX46 was removed from the nude mouse,
disaggregated and injected straight into nude hooded Lister
rats.
Tumour cell suspensions
These were prepared by enzymatic disaggregation of the
tumour fragments augmented with a magnetic stirrer
(Hank's basic salt solution containing 100 igml - I of
bacterial neutral protease and 1 jgml-1 of DNAase was
used). Following washing three times in Hank's (centrifuged
at 900rpm), the cells were either immediately injected or
alternatively they were cultured for a total of 36-48h before
injection - cultured in medium made up from 89% MEM
Eagles medium (containing 5% sodium bicarbonate 7.5%,
1% MEM sodium pyruvate, 1% non-essential amino acids,
1% penicillin/streptomycin solution), 10% foetal calf
solution and 1% glutamine. The medium was changed 16-
24h after the cells had first been put in the flasks. Cells were
then harvested from the flasks 16-24h later using the same
enzymatic preparation and washing methods as above. The
preparations from cultured cells gave suspensions which were
almost entirely made up of single cells whereas preparations
made directly from the tumour frequently contained clumps
of cells. Cell counting was done in an improved Neubauer
counting chamber. The hepatoma and sarcomas grew in vitro
and could be radiolabelled but this did not apply to the
breast carcinoma. Cell viability for the sarcomas, assessed
using trypan blue exclusion, was between 80% and 97%
(though in some instances deliberately poorer cell
preparations were used - see below), and for the hepatoma
was 70%-80%.
Radiolabelling of the tumour cells
The cells were cultured as above, but at the time the media
were changed, 5-[125I]Iodo-2'-deoxyuridine (IUdr) was added
to make a concentration of 0.2 mCi ml 1. Cytospin
preparations of the labelled sarcoma cells were autoradio-
graphed and this confirmed that over 90% of the tumour
cells had taken up the IUdr.
Organ counts
Alcohol extraction of free iodide was performed by the
addition of 70% alcohol to the minced organs and was
replaced every day for 3 days. The organs were counted in a
Wallac Decem series automatic well gamma counter. The
carcass (ie that which remained after removal of the organs)
and skin were counted by placing them 18cm under a lead
Table I Syngeneic rat tumours used
Passages
Tumour used Induced by Comments
Sarcoma MC28 27-32 Methylcholanthrene Low immunogenicity.
Spontaneous metastases
Sarcoma MC24 10-13 Methylcholanthrene High immunogenicity.
Sarcoma HRGClI 4-5 Dimethylhydrazine Both were induced in
attempts to produce
Sarcoma HRGC9 2-4 Dimethylhydrazine colonic tumours.
Hepatoma 130-142 Dimethylaminoazobenzene Anaplastic
Breast carcinoma 5-18 Oestrogen Oestrogen dependent.
OES5 Grew very slowly in
absence of exogenous
s.c. oestrogen pellet.ORGAN SELECTIVE TUMOUR GROWTH 21
shielded gamma camera with a 33 cm diam. crystal.
Radioactivity counts from iodine-125 were partially absorbed
by the carcass of the rat. For the average rat carcass of
- 130 g, absorption was - 13% and all carcass counts were
corrected to allow for this. Using a standard, the carcass and
skin values were then converted to the same scale as the
organ values.
To determine 'arterial' distribution of labelled tumour cells
I1 x 106 labelled sarcoma MC28 or hepatoma cells were
injected in each rat. The rats were killed with pentobarbitone
forte given i.v. Since the number of cells injected varied by
up to 20% between animals, the results for the immediate
and 5min distributions were expressed by summing the total
radioactivity counts to 100% and then the individual organ
values were expressed as fractions of this value. For the later
time points the organs were 'alcohol extracted'. The counts
of the organs that could not be alcohol extracted (ie carcass,
testis and pancreas for technical reasons and bladder and
skin because of contamination with iodine) were excluded.
The remaining organ counts were totalled to 100% and a
'relative cell distribution' was thereby obtained.
Autoradiography
Autoradiography (as described by Rogers, 1969) was also
used to study cytospin labelled tumour cell preparations and
organ sections following vascular injection of labelled cells.
Identification of tumour colonies
The rats were usually killed when the first member of a
group became unwell. The rats were skinned and all sites
except the brain were examined for overt metastases.
Frequent histological examination was made to confirm the
absence or presence of growth in all organs. Bony growths
were most often seen in the ribs. Vertebral growths caused
the rats to develop early paraplegia and their presence was
confirmed by X-radiography.
Bioassay of organsfor the presence ofviable tumour cells or
micrometastases
Organs without overt metastasis were bioassayed for the
presence of microscopic colonies or trapped viable cells (cf.
Alexander, 1983) by i.p. transplantation of the 'minced'
organ to recipient rats. If these contained viable cells they
then grew out in the peritoneum of the recipient.
Distribution ofcardiac output
This was determined by the left ventricular injection of
-~60,000-100,000 Co-57-labelled styrene divinyl benzene
copolymer microspheres into each rat (16.4+0.5,m -
supplied by New England Nuclear). These distribute and
arrest in the organs in the same proportions as the
percentage distribution of cardiac output (Ishise et al., 1980).
The percentage radioactivity in each removed organ
following injection represents a direct measure of the
distribution of cardiac output. Radioactivity counts in the
organs (and the converted carcass and skin counts) were
totalled and taken as the '100% value'. Radioactivity from
Co-57 (unlike that from I-125) was not significantly
attenuated by the carcass and therefore no correction was
needed.
Calculation ofthe 'relative vascularity' ofthe rat's organs
The vascularity of an organ is usually expressed as ml
bloodmin- 1 g-1 of organ and can be determined from the
cardiac output per minute, the percentage distribution of
cardiac output to the organ in question, and the weight of
the organ. Since in our studies only the fractional
distribution of cardiac output and organ weight were
measured and not the cardiac output per minute, a 'relative
vascularity' has been determined by dividing percentage of
cardiac output by the percentage weight of the organ in each
individual rat.
Drugs used in the rats and otherprocedures undertaken
In order to study some the factors that might determine the
site of growth of metastases, dexamethasone, amino-
glutethimide, metyrapone, flurbiprofen and propranolol were
used at dosages stated in the text. Additionally in these
studies a number of rats underwent bilateral adrenalectomies
and were maintained by the addition of normal saline to
their drinking water.
Induction of trauma
Mechanical liver trauma was performed by squeezing the
liver between two fingers across it's width while the rats were
anaesthetized under ether. Partial 2/3 hepatectomies were
performed by ligating the anterior lobes of the liver at their
pedicles and excising them. Chemical liver trauma sufficient
to cause later development of cirrhosis was induced by
giving 0.5mlkg-1 of carbon tetrachloride once via a
nasogastric tube. Muscle trauma was standardised by
performing a routine midline longitudinal laparotomy scar
and then suturing the abdominal musculature in one layer
with linen. No wound infections were observed.
Results
Inability to observe recirculation oftumour cells
Study of organ site selectivity by bloodborne tumour cells
must initially establish how the tumour cells distribute and
localise after entry into the vasculature. In our particular
'model' of vascular spread evidence from several sources
shows that tumour cells mainly arrest on initial delivery to
an organ and do not recirculate after injection via the
different vascular routes used. After i.v. and i.ptl. injection
tumour growth is almost completely localised to lung and
liver respectively (Tables II and III). However, after i.a.
injection tumour colonies form in many organs (Tables IV-
VII). This demonstrates that the failure to cause systemic
tumour growth following i.v. and i.ptl. inoculation is not
because the cells cannot grow in distant organs but is due to
the inability of significant numbers of cells to pass in a
viable state through the capillaries of the lung and liver.
Following the i.v. and i.ptl. injection of radiolabelled
tumour cells, radioactivity was essentially confined to the
lung and liver respectively (Tables VIII-X). The small
amount of radioactivity that was in other organs shortly
after i.v. injection comes from labelled debris and dying cells
contained in the inoculate. This was demonstrated by the i.v.
Table II Pattern of tumour colonisation following the
intravenous injection of unlabelled tumour cells
Tumour type No. ofrats No. ofrats
and with lung developing tumours
(No. ofcells) tumours at distant sitesa
MC28 sarcoma 37/51 0/51
(1 x 103-2 x 106)
MC24 sarcoma 3/3 0/3
(1 to 5 x 106)
Breast carcinoma 16/19 0/19
(1 x 103_1 x 106)
Hepatoma 4/4 0/4
(1 x 106)
HRGCll sarcoma 6/6 0/6
(1 x 106)
aAt times when animals became unwell from lung lesions
(see Materials and methods).22 P. MURPHY et al.
Table III Distribution of tumour colonies in rats after intraportal vein injection
of tumour cells
No. ofrats No. ofrats No. ofrats
Tumour type with liver with lung with distant
(No. ofcells) tumour colonies tumour colonies tumour colonies
Sarcoma MC28 45/88 1/88 0/88
(1 x 103-1 x 106)
Hepatoma 11/13 2/13 0/13
(5 x 105-1 x 106)
Breast carcinoma 10/10 2/10 0/10
(1 x 106)
Cultured and directly disaggregated cell preparations included.
Table IV Sites of overt tumour colonisation in rat organs after left ventricular injection of sarcoma MC28 at different
doses. All cells cultured for 36-48h
No. cells 1-4 x 1010 Jo 104-3 x04 103 102
No. of rats
with tumours 57/57 29/30 12/13 10/15 0/5
No. injected
conscious. 22/57 15/30 13/13 15/15 5/5
Day killed'
Median 15 19 25 32
Range 11-21 15-23 22-32 26-39 -
Adrenals 57/57 (0/57) 29/30 (1/29) 9/13 (1/9) 2/15 (2/2) 0/5
Ovaries 13/14 (1/13) 8/11 (5/8) 8/9 (2/8) 2/10 (2/2) 0/5
Brown fatd 22/22 14/15 10/13 7/15 0/5
Brown fate 19/35 2/15 ND ND ND
Bone 33/57 19/30 7/13 6/15 0/5
Periodontal ligament 32/40C 12/23C 1/13 1/15 0/5
Lungs 19/57 3/30 0/13 2/15S 0/5
Diaphragm 11/57 0/30 0/13 0/15 0/5
Muscle 9/38C 1/17C l/13- 1/15- 0/5
Skin l0/38C 5/17C 0/13 0/15 0/5
Heart 2/57 2/30 0/13 0/15 0/5
Mesentery 5/57 6/30 0/13 0/15 0/5
Yellow fat 8/57 9/30 0/13 1/15a 0/5
Pancreas 2/57 0/30 0/13 0/15 0/5
Liver 1/57 0/30 0/13 0/15 0/5
Kidneysb 0/57 0/30 0/13 0/15 0/5
Intest. 0/57 0/30 0/13 0/15 0/5
Spleen 0/57 0/30 0/1 0/15 0/5
Testis 0/43 0/19 0/4 0/5 ND
Thymus 0/57 0/30 0/13 0/15 0/5
( ) Indicates the frequency with which the adrenals and ovaries developed unilateral metastasis as opposed to both organs
being involved; aSingle metastases in each core; bThese develop microscopic metastases; 'Not all animals were examined for
metastases at these sites; dConscious rats; eAnaesthetized rats; 'Only rats developing metastases included.
injections of deliberately damaged cell preparations which
led to high fractions of radioactivity localising to the liver
while after the injection of a cell preparation cleared of
debris the radioactivity in the liver was low (Table XI). The
debris is presumably cleared by the reticuloendothelial
system. Hepatoma cell preparations contained a greater
proportion of non-viable cells which probably explains the
higher fraction in the liver after i.v. injection (Table IX).
With time radioactivity accumulates in other organs (Table
VIII) but this cannot be due to the release of intact cells
from the lungs into the arterial circulation since the pattern
of radioactivity seen was not the same as that following
injection of labelled cells into the left ventricle.
There were three lines of evidence to suggest that tumour
cells do not recirculate significantly after arterial injection.
Firstly, the labelled tumour cell distribution (values shown
for 5min after i.a. injection) paralleled the distribution of
cardiac output in conscious and anaesthetised rats as shown
in Tables XII and XIII. The cells must have been carried
passively in the blood stream and then arrested on 'first
pass'. The only exceptions are that the cell associated
radioactivity in the liver and lung was much higher than the
proportion of cardiac output to lung and liver. The raised
liver values was in part secondary to clearance of labelled
debris (as already seen after i.v. injection) since injection of
low viability cell preparations resulted in high clearances by
the liver (Table XI). There is probably true transcapillary
passage of some 15% of the cells across the gastro-intestinal
capillary beds to the liver and across the systemic capillary
beds (mainly skeletal muscle) to the lungs. This occurs within
the first 5min after injection and is not significant in terms
of tumour cell recirculation since these cells then arrest in
liver and lung.
Secondly, the consistently higher value for cardiac output
distribution to brown fat seen in conscious rather than
anaethetised rats was reflected both in the increased
distribution of labelled tumour cells to brown fat in
conscious rats (Tables XII and XIII) and the higher
frequency of development of tumour colonies in this organ
in conscious rats (eg as in Table IV) ie further confirming
the passive nature of tumour cell distribution and arrest on
'first pass'. Thirdly the experiments in Table XIV show thatORGAN SELECTIVE TUMOUR GROWTH 23
Table V Frequency of overt colonisation in female rat organs after left ventricular injection of breast
carcinoma at different doses
Number ofcells injected
3 x 105-106 105 104 103
Number of rats
developing metastases 47/48a 3/3 4/4 0/3
No. injected
conscious 4/48 0/3 0/4 0/3
Adrenals 46/48 (0/46) 3/3 (0/3) 3/4 (3/3) 0/3
Ovaries 44/48 (2/46) 3/3 (1/3) 4/4 (1/4) 0/3
Bone 10/48 1/3 2/4 0/3
Periodontal ligament 14/48 2/3 1/4 0/3
Lungs 29/48 3/3 4/4 0/3
Brown fat conscious 1/4 ND ND ND
Brown fat anaesthetised 3/44 0/3 0/4 0/3
Diaphragm 1/48 0/3 0/4 0/3
Skin 3/18 0/3 0/4 0/3
Heart 2/48 0/3 0/4 0/3
Kidneys 2/48 1/3 0/4 0/3
Liver 2/48 0/3 0/4 0/3
Uterus 2/48 0/3 0/4 0/3
Peritoneum 3/40 0/3 0/4 0/3
Muscle 0/18 0/3 0/4 0/3
No tumour developed in the intestines, spleen or thymus. ( ) indicates the number of times the
adrenals and ovaries developed unilateral tumour growths as opposed to both organs being involved;
aPreoestrogenised, late oestrogenised and non-oestrogenised rats were used. Time of oestrogenisation
did not alter the pattern colonisation but affected the rate of appearance ofcolonies.
Distribution of tumour colonisation in male rats after left ventricular injection of tumour cells
Oestrogenised and non-oestrogenised animals all included. 106 cells injected into 13 male rats. All rats
developed metastasis
Adrenal
Lung
Muscle, diaphragm, jaw
Bone, skin, heart, kidney
11/13 (unilateral in 1)
8/13
3/13
1/13
Table VI Frequency of tumour colonisation in rat organs after left
ventricular injection of hepatoma cells at different doses
Number ofcells injected
3 x 105-106 105
No. of rats developing
metastases 13/13 3/3
Adrenals 13/13 (3/13) 2/3 (1/2)
Ovaries 4/4 (1/4) ND
Bone 4/13 3/3
Periodontal
ligament 2/6 0/3
Eyes 2/13 0/3
Kidneys 1/13 0/3
Cultured cells in 7 animals. Directly disaggregated in the
remainder. Tumour colonies were not seen in the lungs, liver,
intestines, spleen, pancreas, mesentery, diaphragm, testes and
thymus. Only 3 of the high dose group of animals were examined
for muscle and skin metastases - none were seen. () Incidence of
tumour growth occurring unilaterally.
the rat's blood was 'bioassay negative' for tumour cells 5min
after i.a. injection. This again demonstrates the rapid
clearance of tumour cells from the blood.
Tissue preferencefollowing arterial injection ('Soil effect):
General pattern and quantitation
Comparison of arterial tumour cell distribution (eg for
sarcoma and hepatoma - see Tables XII and XIII) with the
eventual pattern of tumour growth (see Tables IV and VI)
shows no correlation ie tumour colonisation is site selective.
The overall pattern of tumour growth for all the tumours
studied (Tables IV-VII) show that they have similar site
preferences. Organs such as the adrenals, ovaries,
periodontal ligament and bone were consistently preferred
sites of colonisation, others such as the pancreas, diaphragm,
skin and skeletal muscle only developed tumour colonies
(rarely more than 10 in skin or muscle) following the
delivery of large numbers (106) of tumour cells, while others
such as the intestines, spleen and testes never developed
colonies even after the injection of > 106 cells. Only tumour
growth in the kidneys, brown fat and to a lesser degree the
lungs varied depending on the tumour type injected. Human
tumour cells injected into immunosuppressed rats (Table
XV) tended to grow mainly in the susceptible organs (ie
adrenals, bone and periodontal ligament).
Sarcoma MC28 tumour cells arrested mainly singly and
widely separated from each other - of 100 radiolabelled cells
examined in autoradiographic sections of the adrenal (the
animals were killed 5min after i.c. injection of 1 x 106
labelled cells), all were found in the outer cortex and 86%
were single and 14% were found as two cells together. Of
100 cells examined in the kidneys, 94% were in the glomeruli
and of these 84% were single. Since most cells trapped
singly, and since the approximate percentage of cells
delivered to each organ was known and the frequency of
tumour colonisation for any particular cell dose was also
known, the likelihood of a trapped tumour cell developing
into a tumour colony could be calculated for individual
organs. For example, 3 out of 4 rats developed adrenal
tumour growths (though the number of individual growths
could not be counted since they coalesced) following the24 P. MURPHY et al.
Table VII Frequency of tumour colonisation in rat organs after left ventricular injection
of sarcomas MC24, HRGCll and HRGC9
Tumour Sarcoma MC24 Sarcoma HRGClI Sarcoma HRGC9
Number of animals
developing metastases 10/10 9/9 10/14
Sex m f 1Of,4m
Anaesthetized No Yes 9/14
Number of cells 106-2 x 106 106 5 x105-106
Adrenals 6/10 6/9 (3/6) 9/14 (1/9)
Ovaries - 7/9 (3/7) 5/14 (1/5)
Bone 1/10 4/9 2/14
Periodontal ligament NE 2/9 0/14
Lung 4/10 5/9 4/14
Heart 1/10 0/9 0/14
Pancreas 1/10 0/9 0/14
Mesentery 1/10 0/9 0/14
Yellow fat 1/10 1/9 1/14
Skin 1/7a 3/9 3/14
Muscle l/7a 2/9 2/14
Diaphragm 0/10 0/9 0/14
Intestines 0/10 0/9 0/14
Liver 0/10 0/9 0/14
Spleen 0/10 0/9 0/14
Thymus 0/10 0/9 0/14
Testes 0/10 - 0/4
Kidneys 0/10 7/9a 9/14
Brown fat 10/10 3/gb 2/14
() Incidence of tumour colonisation occurring unilaterally; amultiple tumour colonies;
bsingle tumour colonies. NE =not examined.
Table VIII Percentage distribution of labelled MC28 sarcoma cells after
intravenous injection
Time after
injection Lungs Liver Kidneys Carcassa Total
Immed. (n=3) 93.08+2.80 1.51 +0.32 0.14+0.03 5.27+ 2.60 100%
5min (n = 12) 93.94+2.09 2.50+0.55 0.07+0.05 3.49+ 1.54 100%
4h (n=5) 40.57+8.08 4.75+0.57 0.61 +0.21 27.89+ 8.48 73.8%
8h (n=4) 29.91 +2.61 3.19+0.69 0.62+0.24 35.32+ 10.54 69.0%
16-24h (n=4) 1.03 +0.24 0.47+0.20 0.07+0.03 7.07+ 1.75 8.6%
48h (n=6) 0.13+0.12 0.42+0.08 0.04+0.01 5.45+ 4.22 6.0%
aSkin, bladder and thyroid were removed in the rats killed at the later time
points because of iodine contamination. The immediate and 5min results are
calculated by the addition of all the organ counts and calling the total 100%. This
assumes none of the injected radioactivity has been excreted. The values at the
remaining time points have been calculated from an estimate of the amount of
radioactivity injected.
Table IX Early percentage distribution of labelled hepatoma cells
after intravenous injection
% oftumour cells % oftumour cells
trapping immediately trapping 5min
after i.v. injection after i.v. injection
(n=4) %+s.d. (n=3) %+s.d.
Lungs 87.42+4.71 82.57+2.20
Liver 6.90+3.99 12.56+ 1.07
Kidneys 0.18+0.12 0.22+0.11
Adrenals 0 0
Carcass and
remaining organs 5.5+0.86 4.65+1.36
injection of 104 sarcoma MC28 cells ie following the
approximate delivery of 30 tumour cells to both adrenals.
Therefore I in 30 cells arresting in the adrenals gave rise
to a tumour colony. The figures are similar for the
periodontal ligament and the ovaries. In contrast, over a
thousand times that number of cells arresting in the
intestines or over a hundred times that number arresting in
the spleen (and still 'bioassay positive' 24h later - see Table
XIV) failed to develop into tumour colonies.
Mechanismsfor site selectivity
Rate of autolysis of cancer cells trapped in the capillaries
beds of different organs Autolysis of labelled tumour cells
following i.v. injection (Table VIII) revealed the dis-
appearance of most of the label from the lung and release
into tissue fluids over a few hours. By 8 h 70% of the
radioactivity had disappeared and by 24h 99% had
disappeared. The rate of autolysis over 16h following i.a.
injection of sarcoma MC28 was also studied and was not
greater in those organs refractory to the growth of tumour
emboli than those which are susceptible (Table XVI). The
'soil effect' cannot therefore be simply explained in terms of
the rate at which the trapped cells die within the capillaries.
Relationship to organ vascularity The possibility that site
selection might be directly related to organ vascularity wasORGAN SELECTIVE TUMOUR GROWTH 25
Table X Percentage distribution of radioactivity following intraportal injection of
labelled sarcoma MC28 cells and hepatoma cells
Sarcoma MC28 Hepatoma
Immediately 5min Immediately 5min
after inj. after inj. after inj. after inj.
(n=3) %+s.d. (n=3) %+s.d. (n=3) %+s.d. (n=3) %+s.d.
Liver 95.35 + 1.34 95.86+0.97 95.10+2.15 97.32+2.13
Lungs 0.30+0.04 0.27+0.12 0.79+0.84 0.14+0.06
Kidneys 0.10+0.06a 0.08+0.03a 0.09+0.04 0.06+0.05
Carcass 4.25+1.31 3.79+1.10 4.02+ 1.38 2.48+2.07
aOnly the right kidney counted in these cases. The organ counts were totalled to
make 100% and the percentages were then calculated.
Table XI The effect of cell viability on clearance of radioactivity by
the liver after intravenous injection of sarcoma MC28 cells
% +±s.d. ofradioactivity in the liver 5min
after injection
After i.v. After i.c.
injection injection
(n =3) (n=3)
97% viablea 0.63+0.07b ND
Over 80% viable 7.59+0.69 13.47+ 1.50
Less than 80% viableb 12.49+1.02 20.42+0.33
'Cells separated from debris on a Ficoll gradient and then washed
twice in Hanks before injection; bCells allowed to stand for 4h at
high density during which time the viability decreased.
studied. Although there was a degree of correlation between
susceptibility to tumour colonisation and high organ
vascularity (Table XVII) there were exceptions such as
kidney and heart which were very vascular but not nearly as
susceptible to tumour colonisation as adrenals and ovary.
Measurements of vascularity are however difficult to
interpret since they are likely to be variable and also many
organs are not uniform vascular structures (eg the adrenal or
kidney - each with a cortex and medulla).
Effect of steroids, cyclosporin A and flurbiprofen The liver
did not normally support tumour growth after i.a. injection
of sarcoma MC28 or hepatoma cells and no microscopic
tumour growths could be demonstrated histologically.
However the steroid dexamethasone given s.c. was found to
promote the growth of sarcoma MC28 liver tumour colonies
if given within 24h of tumour cell injection (Table XVIII)
and also in 5 out of 7 rats given 106 hepatoma cells i.a. In
the kidneys microscopic glomerular tumour deposits were
routinely observed after i.a. injection of 106 sarcoma MC28
cells. Although viable cells could be demonstrated on
bioassay these growths did not develop into macroscopic
lesions. However if dexamethasone was given at the time of
tumour injection or as long as two days afterwards large
overt tumour growths developed (Table XVIII).
Attempts were made to ascertain why steroid treatment
potentiated the growth of tumour colonies. Sarcoma MC28
tumour cells injected into animals bilaterally adrenal-
ectomised on day -8, or day +7, or at the same time as the
cancer cells were injected to see if the tumour was steroid
dependent but there was no inhibition of the growth of
tumour in any of the susceptible organs of these rats (data
not shown). To see if tumour potentiation by the steroids
was mediated by T-cell immunosuppression or by the inhib-
ition of prostaglandin synthesis the sarcoma cells were
injected into six rats treated with cyclosporin A given s.c. at
25 mgkg-1 four times weekly commencing one day before
tumour inoculation or flurbiprofen (given 7 mgkg- 1 twice
daily also commencing on day -1 - see Heckford et al., 1982)
respectively. Neither of these treatments caused the develop-
Table XII Comparison of the % distribution of cardiac output
with the % distribution of tumour cells 5min after injection into
conscious rats
% Distribution % Distribution % Distribution
cardiac output sarcoma cells hepatoma cells
Number of m. 7
rats f. 9
Carcassa
Kidneys
Heart
Skin
Brown fat
Brain
Adrenals
Testes
Ovaries
Lungs
Pancreas
Spleen
Small bowel
Large bowel
Stomach
Mesentery
Liver
Organs not m
Diaphragm
Bone
Muscle
m. 40.92+7.23
f. 44.50+7.78
m. 15.12+4.31
f. 11.53+3.76
m. 7.93+3.30
f. 5.87+2.27
m. 9.33 +2.51
f. 5.05+4.69
m. 4.62+2.45
f. 10.12+4.36
m. 3.20+0.75
f. 2.39+ 1.07
m. 0.39+0.20
f. 0.34+0.12
m. 1.19+0.63
f. 0.17+0.15
m. 1.05+0.40
f. 0.75+0.51
m. 2.14+ 1.18
f. 2.45+0.94
m. 0.78 +0.38
f. 0.62+0.27
m. 6.09 + 1.56
f. 8.85+2.67
m. 3.02+0.96
f. 3.35+ 1.30
m. 2.05 + 1.10
f. 1.98 + 1.02
m. 1.00+0.35
f. 0.87+0.37
m. 0.36+0.32
f. 0.59+0.48
11
ND
30.28 +6.89
ND
8.95 +2.83
ND
5.66+ 1.90
ND
6.72+3.38
ND
5.98 +2.53
ND
1.57+0.79
ND
0.19 +0.09
ND
0.83 +0.45
ND
17.33 +5.99
ND
1.06+0.44
ND
0.61 +0.54
ND
4.29+ 1.03
ND
1.68+0.38
ND
0.95 +0.25
ND
0.70+0.25
ND
13.59+2.85
ND
4
ND
21.19+3.88
ND
8.29 +3.66
ND
2.69+1.07
ND
4.67 + 1.46
ND
3.99+0.97
ND
0.99+0.52
ND
0.18+0.10
ND
0.89+0.39
ND
24.45+6.12
ND
1.26+0.53
ND
0.92+0.64
ND
3.25+ 1.47
ND
1.26+0.30
ND
1.09+0.27
ND
0.76+0.52
ND
23.78 +6.39
ND
ieasured in all animals. () No. ofrats
m. 0.28, 0.47 (2)
f. 0.74+0.24 (4)
m/f 7.43+1.16(2m, If)
m/f 40.59 +2.39 (2m, If)
aCarcass =residual muscle and bone. m =male, f=female.
ND=not done.
ment of tumour colonies at lung or liver or altered the
pattern of growth in other organs (data not shown).
Modification ofadrenal metabolism Attempts were made to
influence tumour colonisation in the adrenals by blocking
steroid production using aminoglutethimide in a 3-day
schedule giving 250, 125, 62 mgkg-1 on days -1 through to26 P. MURPHY et al.
Table XIII Comparison of % distribution of cardiac output with
the % distribution of tumour cells 5min after injection into
anaesthetized rats
% Distribution % Distribution
cardiac output sarcoma cells
Number of m.
rats f.
Carcassa m
f.
Kidneys m.
f.
Heart m.
f.
Skin m.
f.
Brown fat m.
f.
Brain m.
f.
Adrenals m.
f.
Testes m.
Ovaries f.
Lungs m.
f.
Pancreas m.
f.
Spleen m.
f.
Small bowel m.
f.
Large bowel m.
f.
Stomach m.
f.
Mesentery m.
f.
Liver m.
f.
8
7
52.65+ 12.73
61.55+ 4.35
9.81+ 4.25
6.84+ 1.03
3.74+ 2.61
4.58+ 2.00
4.56+ 1.75
3.18+ 0.72
1.54+ 1.46
1.00+ 0.47
3.39+ 0.79
3.75+ 1.04
0.39+ 0.11
0.51+ 0.16
1.14+ 0.26
0.37+ 0.29
4.05+ 1.72
3.02+ 1.82
1.59+ 0.52
1.03+ 0.32
0.94+ 0.41
0.95 + 0.55
8.30+ 3.58
6.65+ 1.39
2.59+ 0.95
1.94+ 0.64
1.28+ 0.43
0.73 + 0.28
0.58+ 0.31
0.54+ 0.15
2.65 + 0.98
2.30+ 0.58
Organs not measured in all animals. () No. ofrats
Diaphragm m. ND
f. ND
Jaw m. 0.04, 0.04 (2)
f. ND
6
38.33 + 13.25
38.46+ 7.60
9.38+ 4.30
7.87+ 1.06
6.13+ 3.59
7.22+ 5.11
3.93+ 1.48
3.85+ 1.10
0.72+ 0.23
0.54+ 0.18
2.38+ 1.13
2.14+ 0.60
0.39+ 0.21
0.33+ 0.06
0.76+ 0.12
0.34+ 0.10
18.46+ 3.84
16.83+ 3.23
1.59+ 0.64
1.72+ 0.45
1.02+ 0.45
1.08+ 0.44
4.78+ 2.61
5.48+ 1.24
1.89+ 1.40
3.11+ 1.12
0.93 + 0.30
0.72+ 0.25
0.35+ 0.15
0.46+ 0.24
8.49+ 3.27
9.03+ 3.57
0.75+ 0.10(3)
0.59+ 0.18 (6)
0.03 + 0.01 (3)
0.07+ 0.05 (6)
aCarcass =residual muscle and bone; m =male, f=female;
ND = not done.
Table XIV Bioassays of organs for the presence of viable sarcoma
MC28 cells in animals injected at different times before bioassay and
comparison with the later development of tumour colonisation
studied histologically
Timefollowing tumour cell injection
(1 X 106 cells) at Histological
which the donor was killed and the organs examination
transplanted i.p. into untreated recipients for tumour
growth at
5min I day 5-6 days 15 days
Adrenals 2/2b 2/2 4/4 Overt tumour
Kidneys 2/2 4/4 4/4 Microscopic tumour
Spleen 6/6 2/2 0/4 No tumour
Small int. 1/2 1/2 0/3 No tumour
Blood 1/2ml. 0/3 - 0/1 No tumour
Liver 3/4 0/2 0/4 No tumour
Livera - - 0/5 Tumour rarely
aIn these animals, 105 cells had been injected i.ptl and not by the
left ventricular route. bIncidence of i.p. tumours in recipients.
Table XV Distribution of human tumours following left ventricular
injection into immunosuppressed female rats
Human Human Human
melanoma melanoma carcinoma
(HX34) (HX 46) (HX 70)
No. of rats
developing tumour
colonies 5/5 2/4 1/2
Mode of immuno-
suppression Cyclosporin A Nude rats Cyclosporin A
No. of cells
injected 106 106 5 x106
Adrenals 5/5 1/4 1/2
Bone 1/5 1/4 1/2
Kidneys 3/5 0/4 0/2
Periodontal ligament 0/5 1/4 0/2
No other tumour colonies found.
day +1 respectively; or 125 mgkg day-1 from day 0 and
metyrapone (at 125 mgkg-1 day - from day 0) but neither
inhibited nor delayed the development of tumour growth in
the adrenals or other sites (data not shown). Adrenergic beta
blockade by propranol (2.5 mgkg-1 day-1 from day -1 to
day + 1) also did not alter the pattern or incidence of
tumour growth (data not shown).
Preferential growth at sites oftrauma and healing
In animals undergoing laparotomy followed by the i.a.
inoculation of sarcoma MC28 it was found that tumour
colonies localised to the muscle of the laparotomy wound
(Table XIX). Traumatisation of the muscle (ie the
laparotomy incision) when carried out 2 to 8 days prior to
inoculation of tumour cells was most effective in promoting
tumour growth while an incision at the time of cell injection
was ineffective. A similar phenomenon was observed in 8/12
rats after the i.a. injection of 106 breast carcinoma cells.
In 10 rats that had undergone laparotomy 4 days
previously all developed tumour colonies in the muscle scar
(an average of 4.5 nodules per scar) after the delivery of 105
sarcoma MC28 cells but only 2 developed single tumour
colonies in the rest of the skeletal muscle which received
- 30% of delivered cells (see Table XII). Although the
percentage of cardiac output going to muscle wounds was
higher in the healing muscle -0.77+0.17% as compared to
0.35+0.19% in the same weight of adjacent non-traumatised
muscle (n=5 rats), this cannot account for the very marked
localisation of tumour in the wounds. When quantified (as
already done above for different organs) the probability of
an arrested sarcoma cell in the wound developing into a
colony is -1 in 130 whereas in non-traumatised skeletal
muscle it is - 1,000 times less likely.
Deliberate manipulation of the liver, partial hepatectomy
or treatment with carbon tetrachloride before or around the
time of arteriall inoculation of sarcoma MC28 promoted liver
tumour colony formation (Table XX). Manipulation at the
time of i.ptl. injection of sarcoma MC28 similarly
potentiated the incidence of development of tumour growths
(Table XX).
Promotion of tumour growth in theperitoneal cavity by
pristane
Since trauma potentiated bloodborne tumour colonisation
and since this could not be explained by an increased
delivery of cells alternative mechanisms were examined. The
timing of the promotional effect of trauma in the case for
muscle coincides with the time when macrophages infiltrate
the wound and the importance of these was tested using an
i.p. system. The peritoneal cavity is a favoured site for theORGAN SELECTIVE TUMOUR GROWTH 27
Table XVI Relative percentage distribution of cell associated radioactivity at different time
points following left ventricular injection of labelled sarcoma MC 28 into conscious rats
(Alcohol extracted)
Time after inject. 5min Jh 3h 5h 16h
Total resid. counts 83.63% 68.66% 65.45% 66.57% 19.58%
No. rats (n=3) (n=4) (n=3) (n=3) (n=4)
Heart 16.69+2.37 13.53+ 2.33 12.70+1.61 19.59+7.17 15.36+11.77
Kidney 19.49+3.46 18.31 + 4.51 28.67+6.60 26.70+5.11 50.06+11.06
Brown fat 11.61 +2.37 10.48+ 6.62 14.17+3.40 11.29+3.53 3.85 + 1.05
Brain 4.61 +2.09 5.68+ 4.66 3.18+1.18 3.97+1.49 2.94+ 1.49
Adrenals 0.41 +0.05 0.38 + 0.26 0.15+0.13 0.55+0.22 0.51 + 0.29
Lungs 22.04+3.36 22.98+10.16 19.31 +2.46 18.18+7.71 3.58+ 0.39
Spleen 0.81 +0.32 1.40+ 0.20 1.07+0.28 1.24+0.27 1.14+ 0.39
Small bowel 3.94+1.40 4.59+ 1.87 4.79+1.07 3.99+0.91 6.7 + 0.48
Mesentery 0.97+0.13 0.83+ 0.05 1.19+0.44 1.78+1.36 0.37+ 0.13
Stomach 2.03+0.62 2.61 + 1.62 2.33+0.93 2.31 +0.87 4.31 + 1.54
Large bowel 3.38+0.72 3.13+ 0.98 2.04+0.14 1.25+0.25 1.07+ 0.24
Liver 14.02+1.25 16.08+ 8.71 10.40+0.90 9.15+1.61 9.55+ 1.60
Carcass, skin, pancreas, bladder, thymus and thyroid all excluded for technical reasons.
The rest of the organs were totalled and called 100% at each time point.
Table XVII Relative vascularity in female rats
Anaesthetized (n= 7)
Weight= 185+34g
Conscious (n=9)
Weight=185+35g
Organs with venous
drainage to the lungs
Adrenals
Heart
Ovaries
Left kidney
Right kidney
Left brain
Right brain
Hind brain
Thymus
Thoracic brown fat
Abdominal brown fat
Interscapular brown fat
Uterus
Carcass
Skin
Bladder
Lung
Organs with venous
drainage to the liver
Spleen
Small bowel
Pancreas
Large bowel
Stomach
Small bowel mesentery
Liver
Liver including portal
vein fraction
growth of transplanted sarcomas and hepatomas which
develop as solid tumours. Thus the TD50 (the cell number to
induce tumours in 50% of animals) for MC28 is 3 x 104 cells
when inoculated i.m., of the order of 102 when inoculated
i.p. Moreover bloodborne tumour cells which are dormant in
organs such as lung (Alexander et al., 1985) will grow when
transplanted into the peritoneal cavity.
Intraperitoneal tumour growth of the inoculated sarcomas
and hepatoma was initially confined to the omentum as
discrete nodules, before spread by direct extension to the
mesentery, testicular or fallopian fat, the diaphragm, organ
capsules and muscle wall. Pristane treatment of the rat's
peritoneum produced a macrophage rich ascites which was
maximal between 12 and 18 days later when the number of
mononuclear cells from a peritoneal wash rose from
7.5 x 106 to 19 x 107. By 40 days the number of peritoneal
leukocytes had returned to normal but the omentum was still
enlarged and highly cellular. By 100 days the omentum had
a normal appearance and MC28 sarcoma grew as in control
rats.
Pre-treatment with pristance prior to i.p. injection of cells
greatly facilitated tumour growth as measured by a reduction
in TD50, but was most dramatic in terms of tumour mass
(Table XXI). Although this was difflcult to quantify in the
pristane treated groups as the tumour spread rapidly, by
killing pristane treated rats at 7 and 9 days after tumour
inoculation it could be seen that these tumours had their
origin in the greater omentum.
14.85 +5.30
13.95 +6.87
10.38 +8.96
8.34+ 1.38
8.33 + 1.22
5.86+2.22
2.88+0.90
4.27+ 1.77
3.75 + 1.70
2.06+0.99
0.98+0.50
0.68+0.39
1.81 + 1.95
0.92+0.06
0.18+0.04
0.07
5.09+ 3.43
3.85+2.47
3.60+0.66
2.43+0.79
1.56+0.54
0.91 +0.22
0.58+0.20
0.46+0.11
2.80+0.32
8.61 +2.86
15.49+5.05
5.07+3.04
14.12+4.44
12.73 +5.11
2.36+1.37
2.82+1.24
2.21 +0.78
2.67+ 1.84
14.95+5.12
13.79+8.12
12.70+7.93
0.74+0.49
0.65+0.11
0.30+0.28
0.22+0.27
1.43 + 1.18
2.53+1.09
5.69+1.72
5.30+ 1.98
3.27+0.98
2.62+1.15
0.93+0.51
0.12+0.10
3.63+1.1228 P. MURPHY et al.
Table XVIII Potentiating effect of dexamethazone on liver and
kidney tumour colonisation following left ventricular injection of
sarcoma MC 28
Group A B C E F G H
Day dex.
started -8 -1 -4 to 0 + 1 +2 to +6
Day dex.
stopped -1 Oto +1 +8to +16 +16 +16
Kidney 0/5 0/5 1/6 8/10 3/3 2/2 5/5
Liver 0/5 0/5 0/6 7/10 1/3 1/2 0/5
Adrenal 5/5 5/5 6/6 7/10 3/3 2/2 5/5
Ovary 5/5 5/5 ND ND ND ND ND
Jaw 3/5 1/5 3/6 4/10 2/3 1/2 2/5
Bone 2/5 4/5 4/6 4/10 2/3 1/2 5/5
The groups are divided according to the timing of the treatment in
relation to the timing of the cell injection (day 0). Tumour colonies
were occasionally found in the brown fat, lung, heart, muscle, skin,
diaphragm and mesentery. Group A- 106 cells injected. All other
groups received 105 cells. Group F - 0.1mgday`1 injections. All
other groups were given 1 mg day-'.
Table XIX Incidence of tumour colony formation in
muscle wounds after left ventricular injection of 106
sarcoma MC 28 cells
Number ofrats with
Timing oftrauma in relation tumour colonies
to tumour cell injection in the muscle wound
8 days before 7/8
5 days before 2/2
4 days before 6/6
2 days before 0/2
1 day before 1/8
5min before 1/6
5min after 1/12
1 day after 1/6
2 days after 0/8
3 days after 1/4
4 days after 0/2
30 rats had muscle laparotomies only but the remaining
rats also had a variety of procedures including partial
hepatectomy, liver manipulation and kidney manipulation.
Following i.c. injection of MC28 cells into normal rats we
did not see tumour growth in the omentum but this was
likely to be due to the very low delivery of cells to this organ
(<0.05%). However when 1 x 106 cells were injected
arterially into 5 rats treated with pristane 14 days previously
4 of these had omental tumour colonies
Discussion
Our studies and those of others (eg Greene & Harvey 1964;
Fidler, 1970; Proctor, 1976; Van de Velde et al., 1977;
Becker, 1978; Tarin & Price, 1979; Nanni et al., 1983;
Wilmott et al., 1983; Barnet & Eccles, 1984) show that the
lungs are with few exceptions the preferred site for
bloodborne colonies from 'non-lymphoid' and 'non-
haemopoietic' tumours injected into the systemic veins.
Although the method in these studies whereby tumour cells
are injected into vasculature is very artificial, the lung is also
the commonest site for 'spontaneous' metastases derived
from tumours implanted such that they develop systemic
venous drainage (eg Ketcham et al., 1961; Price et al., 1982;
Nanni et al., 1983; Barnett & Eccles, 1984; Alterman et al.,
1985; Wingen & Schmahl, 1985). Following i.ptl. injection of
tumour cells, the liver is likewise the preferred site of tumour
growth - in both our studies and others (Fisher & Fisher,
1965; Vaage, 1973; Proctor, 1976; Tarin & Price, 1981;
Dingemans & Roos, 1982).
The observation that colonisation of extrapulmonary and
extrahepatic sites after i.v. or i.ptl. injection did not occur
despite the ability of many organs to support tumour growth
following the arterial delivery of low numbers of cells
confirmed that the lung and liver capillary beds were
trapping delivered tumour cells. This general pattern is also
true for many other tumours injected via all three vascular
routes, eg B16 melanoma (i.v. - Fidler, 1970; i.p. -
Dingemans & Roos, 1982; i.a. - Weiss et al., 1984), mouse
mammary tumours (i.v. - Tarin & Price, 1979; i.p. - Tarin &
Price, 1981; i.a. - Jaucaba et al., 1983), mouse KHT sarcoma
(i.v. - Siemann & Mulcahy, 1984; i.a. - Conley, 1979),
mouse sarcoma (i.v., i.p. & i.a. - Vaage, 1973), rat allogeneic
Walker carcinoma (i.v. - Agostino & Clifton, 1965; i.p. -
Fisher & Fisher, 1965; i.a. - Sugarbaker, 1952), rat sarcoma,
(i.v., i.p. & i.a. - Proctor, 1976).
Lymphoid or haemopoietic derived tumours behave
differently and demonstrate the ability to traverse capillary
beds since after i.v. injection they grow preferentially in sites
distal to the lung such as the liver, spleen and bone (Potter
et al., 1957; Kobayashi et al., 1962; Greene & Harvey, 1964;
Pilgrim, 1969; Pilgrim, 1971; Parks, 1974; Sadler &
Alexander, 1976; Brunson & Nicolson, 1978; Hart et al.,
1981; Willmott et al., 1983; Konings et al., 1985) and when
labelled the radioactivity accumulates in the liver, spleen and
intestines rather than the lungs (Hoelzer et al., 1973; Sinha &
Goldberg, 1974; loachim et al., 1976; Sadler & Alexander,
1976). The cells of only a few 'solid' tumours demonstrate
the ability to traverse the lung capillaries (some described by
Greene & Harvey, 1963; Kinsey & Smith, 1959; Zeidman &
Buss, 1952; Alessandri et al., 1981) and also 'especially
selected' variant cell lines derived from B16 murine
melanoma (Fidler & Nicolson, 1976; Brunson et al., 1978;
Tao et al. 1979; Brunson & Nicolson, 1979; Raz & Hart,
1980; Fidler, 1984).
The mechanics of the circulation (Ewing's hypothesis)
therefore determine the localisation of bloodborne colonies
from 'solid tumours' in lung and liver after venous injection
of cells and also determines the comparable localisation of
metastases in the clinical situation (Murphy et al.,
1986,1987). However, from our studies it is apparent that
once tumour cells enter the arterial circulation it is 'soil'
factors that determine the pattern of tumour growth (Paget's
hypothesis). Weiss et al. (1984) observed similar results using
the B16 melanoma in the mouse.
We have shown that arterially injected tumour cells
distribute and arrest in parallel with the distribution of
cardiac output. The results of our cardiac output studies are
similar to those that have been published previously (eg
Foster & Frydman, 1977; Tsuchiya et al., 1978; Ishise et al.,
1980). However, the eventual pattern of tumour growth does
not bear any relation to the pattern of tumour cell arrest or
rate of autolysis. The likelihood of tumour cells surviving in
different organs to become tumour growths (or 'soil effect')
has been quantified in our studies and varies by a factor of
several thousand between susceptible and refractory organs.
Various factors to explain site selectivity by bloodborne
tumour have been postulated and include adhesion between
tumour cells and their target organs (Netland & Zetter,
1984), biochemical factors (Nicolson & Dulski, 1986; Horak
et al., 1986), slow blood flow and attenuated endothelial
linings (eg Tavassoli & Shaklai, 1979), the possession of
different cell surfaces (Irimura & Nicolson, 1984), immuno-
logical factors (Hanna & Fidler, 1981), and the production
in host tissues of growth factors needed for isolated cancer
cells to grow (postulated by Alexander et al., 1985).
Much of the work of Fidler (1984) and co-workers has
emphasized the heterogenous nature of tumours and
consequently the possibility that pre-existing variants in a
tumour may have the potential to metastasize to specific
sites. In contrast our studies and the results of the threeORGAN SELECTIVE TUMOUR GROWTH 29
Table XX Effect of trauma on the development of sarcoma MC 28 liver tumour
colonisation
Timing ofthe trauma
15-1 day immediately Immediately 1-7 days
before cells before cells after cells after cells
1. Tumour growth in rats injected with 106 cells via the mesenteric veinsa
Manipulation ND 13/14 5/5 2/9
Carbon tetrachloride 3/3 ND ND 0/3
2. Tumour growth in rats injected with 106 cells via the left ventricleb
Manipulation 0/8 2/2 3/3 0/4
Partial hepatectomy 3/6 2/2 1/2 0/5
Carbon tetrachloride 2/2 1/1 ND ND
'3/22 non-traumatised animals liver developed tumour colonisation; b1/57 non-
traumatised animals developed liver tumour colonisation.
Table XXI Effect of stimulation of omentum by the mineral oil pristane on tumour growth
in the peritoneal cavity
Tumour size & incidence (no. with
macroscopic tumours/no. in group)
No. ofcells Time rat
Tumour injected i.p.C killed (days)a Control Pristane treatedb
MC28 sarcoma 1,000 14 2/5** 5/5***
500 21 2/5* 5/5***
50 22 0/5 3/5*** 2/5**
MC26 sarcoma 5,000 31 2/5* 5/5***
500 31 1/5* 4/5**
Hepatoma 10,000 35 2/5* 4/5*** 1/5*
Tumour size: *Between I to 10 small tumour nodules confined to the greater omentum;
**Omentum extensively involved but no macroscopic tumour in other visceral organs;
***Tumour had spread to diaphragm, organ capsule and muscle wall. The peritoneum was
widely involved which required the animals to be killed. aThe time after cell inoculation
when the animals were killed was in general the time when the first animals in the pristane
treated group became noticeably unwell. This in most cases coincided with spread of tumour
beyond the omentum; bTreatment with pristane: 2.5ml i.p. for 200g rats given between 12-
17 days prior to i.p. inoculation of tumour cells; CTo avoid growth of tumours along the
needle track, the cells were injected in a relatively large (i.e. 1 ml) volume of fluid.
other studies in the rat in which tumour cells have been
injected (Suemasu et al., 1970; Sugarbaker, 1952; Proctor,
1976) show a broad similarity of arterial pattern of tumour
colonisation. In man the 'arterial pattern' of carcinoma
metastasis is also similar whatever the carcinoma type,
whether it is primary lung tumour or lung metastasis
discharging cells into the arterial circulation (Murphy et al.,
1987). Thus we have studied factors affecting organ
environments rather than cell variants with specific site
selectivities.
Our initial approach to the study of site selectivity was
pharmacological. We observed that dexamethasone
promoted sarcoma MC28 tumour colonisation in the liver
and kidneys (organs which did not normally develop overt
growth of tumour colonies) and hepatoma colonisation in
the liver. The mechanisms of this effect remain unclear. If
this promotion were secondary to the immunosuppressive
effects of steroids, then it is not mediated by immunological
factors relating to T-cell action since cyclosporin A did not
have this promotional effect. Furthermore it does not seem
to be mediated by the prostaglandin synthesis inhibiting
action of steroids (Samuelsson et al., 1979) since the non-
steroidal anti-inflammatory flurbiprofen (also inhibiting
prostaglandin synthesis - Heckford et al., 1982) did not alter
the arterial colonisation pattern. Hydrocortisone is known to
facilitate the growth in vitro of freshly explanted cancer cells
from human cancers and is routinely added to media used to
clone human tumours. While it is tempting to attribute
tumour colony promotion by dexamethasone in the kidney
and liver to a mitogenic activity of corticosteroids, the failure
of dexamethasone to induce tumour colonies at other sites
such as intestines renders this hypothesis improbable.
Our second approach was to study the mechanisms
underlying tumour growth in the adrenals. Preferential
adrenal gland metastasis is not only a feature in the rat but
is also observed in man (Murphy et al., 1987), in the rabbit
(Coman et al., 1951; Knisely & Mahaley, 1958; Alexander &
Altemeier, 1964), and in the mouse (Vaage, 1973; Conley,
1979; Jaucaba et al., 1983; Weiss et al., 1984). In the
instances of extrapulmonary tumour growth occurring in
mice after i.v. injection of tumour cells, adrenal or ovarian
involvement is again fairly common (Fidler & Nicolson,
1976; Brunson et al., 1978; Raz & Hart, 1980; Willmott et
al., 1983; Siemann & Mulcahy, 1984; Barnett & Eccles, 1984;
Stackpole et al., 1985; Alterman et al., 1985). Our autoradio-
graphic studies showed that the sarcoma MC28 tumour cells
arrested in the periphery of the adrenal cortex - probably
where the branching arterial subcapsular plexus breaks up
into cortical capillaries (Coupland, 1974). Tumour growth
was also usually in this region and this prompted the
question as to whether the locally high concentration of
steroids might be promoting tumour formation (especially
since steroids potentiated growth in the liver and kidneys).
Attempts to block steroid production in the adrenals with
aminoglutethimide and metypyrone did not inhibit or delay
the development of adrenal tumour colonies or colonies at
other sites. However these drugs do not block steroid
production completely (Temple & Liddle, 1970) and no30 P. MURPHY et al.
definite conclusion is therefore possible. Adrenalectomy was
also not found to delay the development of metastases at
other sites suggesting that factors other than steroid
concentration were more important in metastasis growth. We
have not attempted to test the role of catecholamines by
interfering with tissue levels but rather by blocking beta
action with propranolol. However this did not alter the
pattern or incidence of colony formation.
Trauma has been observed to facilitate the growth of
bloodborne tumour and this confirms earlier studies of
Robinson and Hoppe (1962), Alexander and Altemeier
(1964) and Agostino and Clifton (1965). Although we have
shown an increased delivery of blood (and hence tumour
cells) to damaged and healing muscle in our experiments this
is insufficient to explain the marked susceptibility of this
muscle to bloodborne tumour growth. Tissue healing of all
kinds can be broadly divided into 3 phases - an initial
inflammatory (exudative) phase, a proliferative phase and a
reorganisation or remodelling phase (Leibovich & Ross,
1975; Forrest, 1983). There is initial platelet activation and
coagulation and then loss of fluid into the extravascular
spaces. Neutrophils also extravasate and reach a peak level
after 2 days and then decrease. Macrophages peak at about
3 days, persist for longer, and are important in both
phagocytosis and stimulating tissue repair (Leibovich &
Ross, 1975). This is then followed by a process of
neovascularisation and repair or regeneration.
The timing of trauma potentiation of tumour colonisation
in the muscle wounds coincided with the arrival of the
macrophages and the possibility was considered that these,
while promoting healing, might also promote tumour
growth. Pristane introduced into the peritoneum will induce
a general inflammatory reaction but it is characterised
largely by a macrophage response. Pretreatment with
pristane prior to i.p. tumour cell injection potentiated
tumour growth. Macrophages might therefore be implicated
in promoting tumour growth in these circumstances but the
point is not proven. If this potentiation were secondary to
the increased numbers of macrophages then it might be
because of the many types of polypeptide growth factors
they produce - including PDGF and EGF (Leslie et al.,
1984; Hamburger & White, 1986; Nordan & Potter, 1986;
Morne et al., 1986; Rich, 1986).
For trauma potentiation of liver tumour growth to occur
tumour cell inoculation and trauma have to be timed much
more closely, ie before the macrophage response has time to
develop. This would indicate that promotion of growth of
tumour emboli in the liver by trauma is unlikely to be
caused by macrophages. Nor do we have any reason for
attributing preference for tumour colonisation in normal
non-traumatised organs such as adrenal or ovary to
macrophages.
This investigation was supported by grants from the Cancer
Research Campaign. We wish to acknowledge the help from Dr.
S.A. Eccles of the Institute of Cancer Research who provided us
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